A randomized clinical trial on the effect of combining modified Gualouxiebaiguizhi Decoction with Enhanced External Counterpulsation to treat coronary slow flow

A clinical research on the effect of combining modified Gualouxiebaiguizhi Decoction with Enhanced External Counterpulsation to treat coronary slow flow

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR2200005991

Enrollment

Unknown

Registered

2022-05-11

Start date

2023-01-01

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary slow flow

Interventions

1:preventive therapy for CVD

2:preventive therapy and joint application of modified Gualouxiebaiguizhi Decoction and enhanced external counterpulsation

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: age between 18-75, no gender restriction; meet with the criteria of CSF; meet with the criteria of TCM heart yang deficiency with phlegm and blood stasis syndrome

Exclusion criteria

Exclusion criteria: patients with severe heart, lung, liver, kidney or brain disease;patients with acute infection or bleeding disorders; severe endocrine or electrolyte disorders; uncontrolled blood pressure; organ fibrosis; pregnant or breastfeeding women; patients with mental disorders or epidemic diseases; patients involved in another clinical trial.

Design outcomes

Primary

Measure	Time frame
SF-12;SAQ;indicators of blood stickiness;effectiveness rate of;TCM symptom score;ECG;	—

Countries

China

Contacts

Public ContactXianwen Tang

1647662756@qq.com13922841606

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026